Publikationen
ausgewählte Publikationen
Schatz LM, Greppmair S, Kunzelmann AK, Starp J, Brinkmann A, Roehr A, et al. Predictive performance of multi-model approaches for model-informed precision dosing of piperacillin in critically ill patients. International Journal of Antimicrobial Agents 2024:107305. https://doi.org/10.1016/j.ijantimicag.2024.107305
Greppmair S, Brinkmann A, Roehr A, Frey O, Hagel S, Dorn C, Marsot A, El-Haffaf I, Zoller M, Saller T, Zander J, Schatz LM, Scharf C, Briegel J, Minichmayr IK, Wicha SG, Liebchen U. Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting. Intensive Care Med 2023;49:966–76. https://doi.org/10.1007/s00134-023-07154-0
Schatz LM, Brinkmann A, Röhr A, Frey O, Greppmair S, Weinelt F, et al. Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy. Antimicrob Agents Chemother 2023;67:0010423. https://doi.org/10.1128/aac.00104-23
Ramadan O, Schatz LM, van den Heuvel I, Masjosthusmann K, Groll AH, Hempel G. Developing a Method for Quantifying Meropenem in Children-Volumetric Adsorptive Microsampling Versus Plasma Sampling. Ther Drug Monit 2023;45(5):623–30. https://doi.org/10.1097/FTD.0000000000001105
Schatz LM, Zoller M, Scharf C, Liebchen U. Therapeutisches Drugmonitoring und pharmakokinetische Modelle als Strategie zur rationalen Antibiotikatherapie bei IntensivpatientInnen. Anaesthesiologie 2022;71:495–501. https://doi.org/10.1007/s00101-022-01150-7
Pettelkau J, Ihling ChH, Frohberg P, Van Werven L, Jahn O, und Sinz A Reliable Identification of Cross-Linked Products in Protein Interaction Studies by C-13-Labeled p-Benzoylphenylalanin. J. Am. Soc. Mass Spectrom. 2014, 25, 1628-1641. [mehr]